Publications by authors named "David T MacLaughlin"

Claim this Profile
M
Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway.
Sang Ho Park, Youn Jee Chung, Jae Yen Song, Sang Il Kim, David Pépin, David T MacLaughlin

Int J Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis.
Youn Jee Chung, Hyun Jung Kim, Sang Ho Park, Joo Hee Yoon, Mee Ran Kim, David T MacLaughlin

Int J Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors.
Jang Heub Kim, David T MacLaughlin, Patricia K Donahoe

Obstet Gynecol Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis.
Jeong Namkung, Jae Yen Song, Hyun Hee Jo, Mee Ran Kim, Young Oak Lew, David T MacLaughlin

J Clin Endocrinol Metab· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.
Jae Yen Song, Hyun Hee Jo, Mee Ran Kim, Young Oak Lew, Ki Sung Ryu, David T MacLaughlin

Int J Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.
Katia Meirelles, Leo Andrew Benedict, David Dombkowski, David Pepin, Frederic I Preffer, David T MacLaughlin

Proc Natl Acad Sci U S A· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Mikko Anttonen, Anniina Färkkilä, Hanna Tauriala, Marjut Kauppinen, David T Maclaughlin

Lab Invest· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Müllerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons.
Andrew N Clarkson, Caroline L Talbot, Pei-Yu Wang, David T MacLaughlin, Patricia K Donahoe

Exp Neurol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.
Seong Jin Hwang, Min Jung Suh, Joo Hee Yoon, Mee Ran Kim, Ki Sung Ryu, David T Maclaughlin

Int J Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rate of in vitro maturation of primary follicles from adult mice and the quality of oocytes is improved in the absence of anti-mullerian hormone.
Joo Hyun Park, David T Maclaughlin, Jose M Teixeira

Reprod Sci· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.
Henry L Chang, Rafael Pieretti-Vanmarcke, Fotini Nicolaou, Xianlin Li, Xiaolong Wei, David T MacLaughlin

Gynecol Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
Xiaolong Wei, David Dombkowski, Katia Meirelles, Rafael Pieretti-Vanmarcke, Paul P Szotek, David T MacLaughlin

Proc Natl Acad Sci U S A· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.
Thanos D Papakostas, Rafael Pieretti-Vanmarcke, Fotini Nicolaou, Aristomenis Thanos, George Trichonas, David T MacLaughlin

Protein Expr Purif· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.
David T MacLaughlin, Patricia K Donahoe

Future Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
Henry L Chang, Nima Pahlavan, Elkan F Halpern, David T MacLaughlin

Gynecol Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
Jae Yen Song, Keun Young Chen, Sue Yeon Kim, Mee Ran Kim, Ki Sung Ryu, David T MacLaughlin

Int J Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells.
Suk Woo Nam, Yun Sung Jo, Jung Woo Eun, Jae Yen Song, Ki Sung Ryu, David T Maclaughlin

Int J Mol Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct.
Akihiro Fujino, Nelson A Arango, Yong Zhan, Thomas F Manganaro, Xianlin Li, David T MacLaughlin

Dev Biol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.
David B Seifer, David T Maclaughlin

Fertil Steril· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.
Sibel Kantarci, Lihadh Al-Gazali, R Sean Hill, Dian Donnai, Graeme C M Black, David T MacLaughlin

Nat Genet· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
David B Seifer, David T MacLaughlin, Howard S Cuckle

Hum Reprod· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Vandana Gupta, Giminna Yeo, Hirofumi Kawakubo, Vivek Rangnekar, Preethi Ramaswamy, David T MacLaughlin

Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.
Rafael Pieretti-Vanmarcke, Patricia K Donahoe, Lisa A Pearsall, Daniela M Dinulescu, Denise C Connolly, David T MacLaughlin

Proc Natl Acad Sci U S A· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.
Paul P Szotek, Rafael Pieretti-Vanmarcke, Peter T Masiakos, Daniela M Dinulescu, Denise Connolly, David T Maclaughlin

Proc Natl Acad Sci U S A· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis